Last Price
0.755
Today's Change
-0.035 (4.43%)
Day's Change
0.75 - 0.80
Trading Volume
44,093
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Steven M. Shum Mr. Steven M. Shum
Full Time Employees: 25 25
IPO Date: 2020-11-02 2020-11-02
CIK: 0001417926 0001417926
ISIN: US44984F4019 US44984F4019
CUSIP: 44984F302 44984F302
Beta: 1.44 1.44
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.